Kenjiro Fukase

Results of a phase II study comparing three dosing regimens of fulvestrant in postmenopausal women with advanced breast cancer (FINDER2)

Kathleen I. Pritchard, Janusz Rolski, Zsuzsanna Pápai et al. · Breast Cancer Research and Treatment · 2010 · 89 citations

Medicine, Oncology, Pharmacology +11

Cediranib in combination with mFOLFOX6 in Japanese patients with metastatic colorectal cancer: results from the randomised phase II part of a phase I/II study

Tadafumi Kato, Kei Muro, Kensei Yamaguchi et al. · Annals of Oncology · 2011 · 15 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Safety and tolerability of selumetinib as a monotherapy, or in combination with docetaxel as second-line therapy, in Japanese patients with advanced solid malignancies or non-small cell lung cancer

Takashi Seto, Fumihiko Hirai, Hideo Saka et al. · Japanese Journal of Clinical Oncology · 2017 · 14 citations · Full text

Medicine, Oncology, Pharmacology +12

Real World Treatment Practices for Mantle Cell Lymphoma in Japan: An Observational Database Research Study (CLIMBER-DBR)

Koji Izutsu, Junji Suzumiya, Jun Takizawa et al. · Journal of Clinical and Experimental Hematopathology · 2021 · 10 citations · Full text

Medicine, Hematology, Oncology +17